KD Logo

Cabot Corp. (CBT) receives a Hold rating from Deutsche Bank

Cabot Corp.’s filing revealed that its SVP and General Counsel Kalita Karen A unloaded Company’s shares for reported $1.4 million on May 10 ’24. In the deal valued at $101.73 per share,13,764 shares were sold. As a result of this transaction, Kalita Karen A now holds 34,312 shares worth roughly $3.51 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Kalkstein Hobart sold 7,648 shares, generating $673,094 in total proceeds. Upon selling the shares at $88.01, the Executive Vice President now owns 61,688 shares.

Before that, Keohane Sean D sold 17,857 shares. Cabot Corp. shares valued at $1,525,564 were divested by the President and CEO at a price of $85.43 per share. As a result of the transaction, Keohane Sean D now holds 331,174 shares, worth roughly $33.85 million.

Deutsche Bank downgraded its Cabot Corp. [CBT] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in late March with a ‘”a Buy”‘ rating. UBS also remained covering CBT and has decreased its forecast on January 08, 2024 with a “Neutral” recommendation from previously “Buy” rating. JP Morgan revised its rating on June 06, 2023. It rated CBT as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of CBT

On Tuesday, Cabot Corp. [NYSE:CBT] saw its stock jump 0.05% to $102.22. Over the last five days, the stock has gained 1.14%. Cabot Corp. shares have risen nearly 22.42% since the year began. Nevertheless, the stocks have risen 47.91% over the past one year. While a 52-week high of $103.46 was reached on 05/07/24, a 52-week low of $63.73 was recorded on 02/05/24. SMA at 50 days reached $92.70, while 200 days put it at $78.78. A total of 0.27 million shares were traded, compared to the trading of 0.26 million shares in the previous session.

Levels Of Support And Resistance For CBT Stock

The 24-hour chart illustrates a support level at 101.85, which if violated will result in even more drops to 101.48. On the upside, there is a resistance level at 102.90. A further resistance level may holdings at 103.57. The Relative Strength Index (RSI) on the 14-day chart is 75.17, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.11, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.07%. Stochastics %K at 88.95% indicates the stock is a selling.

The most recent change occurred on March 13, 2023 when Credit Suisse began covering the stock and recommended ‘”an Outperform”‘ rating along with a $94 price target.

Most Popular